is an important regulator of tumor occurrence and deterioration, while MAP3K2 and PBX3 genes are involved in cancer cell proliferation and apoptosis. In this study, the expression of miR-302a and MAP3K2/PBX3 were evaluated by qPCR in liver cancer cell lines. Next, the target relationship between miR-302a and MAP3K2/PBX3 was verified using luciferase assays. Meanwhile, the expression correlation between miR-302a and target genes was analyzed in cancer tissue and para-cancerous tissue. In addition, an increased miR-302a level in HepG2 cells and SMMC-7721 cells were achieved through transfection with miR-302a mimics, and the effects on HepG2 cell and SMMC-7721 cell proliferation, apoptosis and MAPK pathways were determined using MTT, flow cytometry, qPCR and western blot assays. The results showed that liver cancer cell lines exhibited low miR-302a expression and MAP3K2 and PBX3 were confirmed to be the target genes of miR-302a. Meanwhile, the HE results showed that cells became enlarged with loose cytoplasm and formed balloon-like lesions in HCC specimens and we found a significant negative correlation between miR-302a and MAP3K2/PBX3 expression. In addition, treatment with miR-302a mimics inhibited HepG2 cells and SMMC-7721 cells proliferation and increased the apoptosis rate. Further research revealed that the MAPK key factors p-p38, p-ERK1/2 and p-JNK were significantly reduced in miR-302a transfected cells and MAP3K2/PBX3 silenced cells. Besides, MAP3K2 and PBX3 overexpression in miR-302a mimics-treated cells exerted the opposite effects. In conclusion, miR-302a inhibited proliferation and promoted apoptosis in human hepatoma cells by targeting MAP3K2 and PBX3.
inhibit glioma cell and colon cancer cell proliferation [12] [13] [14] . Recently, a new miR-302a/VEGFA axis is identified and found to be involved in HCC formation and progression. miR-302a is expressed at lower levels in HCC tissues and cell lines than matched NATs. Reduced miR-302a expression is correlated with tumor-node-metastasis stage and lymph node metastasis in patients with HCC 15 . Bioinformatic prediction and analysis results showed that mitogen-activated protein kinase kinase2 (MAP3K2, MEKK2) and pre-B-cell leukemia homeobox 3 (PBX3) were possible target genes of miR-302a. Studies have confirmed that MAP3K2 is involved in several cancer types and is closely relate to the risk of mortality. In breast tumor cells and lung cancer cells, MAP3K2 plays a pivotal role in promoting cell proliferation 16, 17 . Meanwhile, MAPK signaling genes can increase the risk of colorectal cancer and have been associated with poor prognosis in squamous cell carcinoma 18, 19 . PBX3 is also found to participate in the regulation of a variety of tumors, such as glioma 15 , gastric cancer (GC) 20 and invasive prostate cancer 21 , and elevated PBX3 expression significantly promote tumor cell proliferation. Furthermore, both MAP3K2 and PBX3 participate in HCC regulation 20, [22] [23] [24] . MAP3K2 may be involved in the regulation of MAPK signaling pathway in cancer deterioration by KEGG analysis. And it is well known that MAPK pathways regulate cellular functions including cell proliferation, differentiation, migration, and apoptosis 25, 26 . MEKK2 is a serine/threonine kinase that functions as a MAPK kinase kinase (MAP3K) to regulate activation of MAPKs 7, 27 . Meanwhile, the MAPK kinase kinase MEKK2 is essential for activation of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) 28 . Furthermore, MEKK2 immunoprecipitates activated c-Jun in an IL-1 dependent manner and this activity is inhibited by the selective JNK inhibitor SP600125. Of interest, MEKK1 immunoprecipitates from IL-1-stimulated FLS appeared to activate c-Jun through the JNK pathway and TAK1 activation of c-Jun is dependent on JNK, ERK, and p38 29 . In addition, PBX3 knockdown inhibits MAPK pathway activation in glioma cells. As shown in research, PBX3 knockdown significantly reduces the phosphorylation level of p38 and ERK1/2. Taken together, the results indicate miR-320 may suppress glioma cell growth through targeting PBX3 and regulating MAPK pathway 30 . However, the role of miR-302a in HCC pathogenesis and progression through the target genes and its impact on growth-regulatory pathways remains unclear.
In this study, the target relationship between miR-302a and MAP3K2/PBX3 was predicted and verified. And miR-302a, MAP3K2 and PBX3 expression levels were detected in liver cancer cells and tissues. In addition, the effect of miR-302a on MAPK signaling pathways, cell proliferation and apoptosis was examined in HepG2 cells and SMMC-7721 cells. The data will lay a theoretical foundation for HCC early diagnosis and treatment.
Results

MAP3K2
and PBX3 are target genes of miR-302a. First, we examined the expression of miR-302a in normal liver cells L02 and liver cancer cells. Results showed that low miR-302a expression was found in liver cancer cell lines (HepG2, Bel-7402, SMMC-7721 and PLC) compared with control group (L02) cells (Fig. 1A) (P < 0.01). The result suggesting that miR-302a might be involved in HCC.
After that, according to bioinformatics software prediction, 1012 possible target genes were searched. First, MAP3K2 and PBX3 were predicted to strongly bind with miR-302a. In addition, GO analysis and KEGG analysis showed that MAP3K2 and PBX3 participated in cancer regulation. Therefore, MAP3K2 and PBX3 were selected from the pool of 1012 possible targets. We identified miR-302a binding sites within the 3′UTRs of MAP3K2 and PBX3, as shown in Fig. 1B . For validation of the potential targets, luciferase activity was analyzed. As shown in Fig. 1C , compared with the miR-302a mimics + Report-si group, luciferase activity was lower in cells co-transfected with miR-302a mimics + MAP3K2-WT vectors (P < 0.01), and no significant difference was observed in the miR-302a mimics + MAP3K2-mut group. Analogously, luciferase activity was significantly lower in the miR-302a mimics + PBX3-WT transfected cells than in the miR-302a mimics + Report-si/PBX3-mut group (P < 0.01). As indicated above, MAP3K2 and PBX3 were both target genes of miR-302a. Moreover, miR-302a significantly inhibited MAP3K2 and PBX3 mRNA and protein expression levels ( Fig. 1D , P < 0.01) (Supplementary Figure S4) .
Morphology observation and correlation between miR-302a and target genes in HCC tissues. The morphology of HCC and adjacent tissues was analyzed under a microscope, and representative images were shown in Fig. 2 . In Fig. 2A and B, the HE-stained HCC tissues showed a typical HCC morphology. The cells in HCC specimens were enlarged with loose cytoplasm and formed balloon-like lesions. The adjacent tissues showed normal liver cell morphology and mild hepatic steatosis with a small amount of inflammatory cell infiltration ( Fig. 2C and D) .
Then, we examined the expression of mature miR-302a and MAP3K2/PBX3 in HCC and adjacent tissues. As shown in Fig. 2E , in 10 HCC patients, the expression of mature miR-302a was significantly lower in HCC specimens than in adjacent tissues from the same patients (P < 0.01). The analysis of miR-302a expression in clinical cases was convincing due to primer verification and the relative expression detection results of miR-302b, miR-302c and miR-302d ( Supplementary Figures S1 and S2) . However, the target gene mRNA expression showed the opposite trend (Fig. 2E) (P < 0.01). The data showed that miR-302a was negatively correlated with MAP3K2 mRNA in HCC tissues (Fig. 2F ) (R = −0.325, P < 0.05) and was also negatively correlated with PBX3 ( Tables S2 and S3 ). When the cells were transfected with miR-302a mimics, the apoptosis level was significantly increased (Fig. 3B and E, P < 0.01) (Supplementary Figure S3 and Table S4 ). In addition, the tumor marker ALDH1 and cell proliferation-and apoptosis-related factors, including Cyclin A, Cyclin D, Caspase-3 and Bcl-2, played an important role in HCC development and cell proliferation and apoptosis processes. Therefore, we examined their expression. In our western blot assay, the expression levels of Cyclin A, Cyclin D and Bcl-2 were significantly down-regulated in cells transfected with miR-302a mimics compared with cells in the miR-shNC group. Meanwhile, the Caspase-3 level was up-regulated. Moreover, miR-302a significantly reduced the expression of p-p38, p-JNK and p-ERK ( Fig. 3C and F) (Supplementary Figure S4) .
Effect of MAP3K2 and PBX3 on MAPK signaling pathways. Since MAP3K2 or PBX3 are involved in regulation of the MAPK signaling pathway, we further verified the HCC regulation mechanism by MAP3K2 and PBX3 RNA interference. MAP3K2 or PBX3 mRNA and protein expression levels were significantly lower in The HE-stained HCC tissues in A (×200) and B (×400) showed a typical HCC morphology, and the adjacent tissues showed a normal liver cell morphology (C ×200 and D ×400). (E) The expression of miR-302a, MAP3K2 and PBX3 were detected in 10 HCC tissues and 10 adjacent tissues by qPCR (**P < 0.01).
(F) Linear correlation was applied to analyze the correlation between the miR-302a and MAP3K2 or PBX3 mRNA expression levels (**P < 0.01). Statistical analysis was conducted using Student's t-test and Fisher's least significant difference (LSD) method of two-way analysis of variance (ANOVA). Tables S5, S6 and S9, Figure S7 ). As shown in Fig. 5D , higher PBX3 expression was observed in cells transfected with miR-302a mimics + Over-PBX3 vector (P < 0.05) (Supplementary Figure S6) . In addition, higher PBX3 levels activated the cell proliferation ability (Fig. 5E , P < 0.05) (Supplementary Tables S7 and S8 ). Furthermore, the apoptosis rate was significantly inhibited (Fig. 5F , P < 0.05) (Supplementary Figure S8) . These results indicated that MAP3K2 and PBX3 reversed the regulation effect of miR-302a on cell proliferation and apoptosis both in HepG2 cells and SMMC-7721 cells.
Discussion
Previous studies have shown that miR-302a is widely involved in the proliferation, migration, and invasion of cancer cells. In osteosarcoma cells, miR-302a inhibits cell migration and invasion by directly targeting IGF-1R, and miR-302a can target GAB2, CXCR4, SDF1, Cyclin A, and Cyclin D to suppress cell proliferation, migration and invasion in glioma 12, 14, 31, 32 . Meanwhile, miR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1
33
. MiR-302a exits higher expression in matched NATs. And miR-302a inhibits cell proliferation and invasion and induces cell apoptosis in hepatocellular carcinoma by directly targeting VEGFA 15 . In the present study, miR-302a expression was significantly lower in HCC tissues than in adjacent tissues (P < 0.01). In addition, miR-302a inhibited HepG2 and SMMC-7721 cells proliferation and promoted cell apoptosis by targeting MAP3K2 and PBX3. These results were consistent with those of previous studies. Therefore, miR-302a might serve as a biomarker in HepG2 and SMMC-7721 cells. One limitation of this study is that only two of over a thousand predicted targets were assayed here because MAP3K2 and PBX3 could bind strongly with miR-302a. Both two genes had a close relationship with cancer deterioration. Therefore, MAP3K2 and PBX3 were selected from the pool of 1012 possible targets. More target genes will be validated, and the interaction between genes will be analyzed in our subsequent experiments. In addition, GO analysis and KEGG analysis showed that MAP3K2 can act as stress-activated protein kinase in MAPK signaling pathway, and also, PBX3 can participate in the regulation of MAPK pathway 30 . It has been shown that MEKK2 mediates the activation of MAPKs, JNK1 and ERK 34 . Meanwhile, studies demonstrate that Src kinase activity is required for ERK activation in response to EGF, MEKK2 expression is required for ERK activation by Src, Lad and MEKK2 association is required for Src activation of ERK, and EGF and Src stimulation of ERK-regulated MEF2-dependent promoter activity requires a functional Lad-MEKK2 signaling complex 35 . In Figure 5 . Cell proliferation ability and apoptosis rate could be rescued by MAP3K2 or PBX3. HepG2 cells and SMMC-7721 cells were cultured and transfected with miR-302a mimics, miR-302a mimics + Over-MAP3K2, miR-302a mimics + Over-PBX3 or miR-shNC. (A-C) Overexpression of MAP3K2 could significantly increase the MAP3K2 expression in cells. Then higher expression of MAP3K2 could promote cell proliferation and reduce apoptosis (*P < 0.05, **P < 0.01). (D-F) Overexpression of PBX3 could rescue the expression of PBX3 in HepG2 and SMMC-7721 cells. Then higher expression of PBX3 could promote cell proliferation and reduce apoptosis (*P < 0.05, **P < 0.01). Statistical analysis was conducted using Fisher's least significant difference (LSD) method of two-way analysis of variance (ANOVA). 37 . But in other research, Puerarin inhibited proliferation of SMMC-7721 cells and promoted their apoptosis in a dose-and time-dependent fashion (p < 0.05). Both the expression and phosphorylation levels of MAPK proteins were dramatically increased on puerarin treatment 38 . However, in our study, MAP3K2 and PBX3 could promote HepG2 and SMMC-7721 cells proliferation and inhibit cells apoptosis rate partially through achieving phosphorylation levels of MAPK proteins.
In conclusion, miR-302a regulates HepG2 cells and SMMC-7721 cells apoptosis and proliferation by targeting the MAP3K2 and PBX3 genes and partially through MAPK signaling pathways. These findings might provide novel insight into the molecular mechanisms of HCC progression and show that miR-302a is a potential biomarker.
Materials and Methods
Tissue samples, cell lines and vectors. HCC tissues and adjacent tissues were collected from 10 patients treated at the First Affiliated Hospital of Jilin University. Patient age ranged from 30 to 65 years old, and the cohort was evenly composed of men and women. All specimens were diagnosed by pathology (Supplementary  Table S1 ). Then, PBS was used for cleaning, and all the samples were cut into two pieces: one was frozen for qPCR detection, and the other was immediately fixed in 4% formalin for HE staining and analysis. The study was approved by the Ethics Committee of the First Affiliated Hospital of Jilin University. All research was performed in accordance with relevant guidelines. All subjects provided written informed consent to participate in the study. L02, Bel-7402, SMMC-7721, PLC and HepG2 cells were purchased from ATCC (HB-8065, USA). Bioinformatics prediction. According to the paired bases and binding energy values, the bioinformatics software microRNA.org (http://34.236.212.39/microrna/home.do), miRDB (http://www.mirdb.org/), miRGen (https://omictools.com/mirgen-tool), and TargetScan (http://www.targetscan.org/vert_71/) were used to predict the target genes of miR-302a, including the MAP3K2 and PBX3 genes. In addition, GO analysis and KEGG analysis showed that MAP3K2 and PBX3 were involved in cancer regulation. Therefore, MAP3K2 and PBX3 were selected from the pool of 1012 possible targets.
Cells were cultured according to the method reference manual. Vectors for miR-302a mimics, miR-302a inhibitor and miR-shNC were purchased from Gene-Pharma Company in China. The pmiR-RB-REPORT-MAP3K2/ PBX3-mut, pmiR-RB-REPORT-MAP3K2/PBX3-WT, PBI-CMV3-MAP3K2, PBI-CMV3-PBX3, siMAP3K2
HE staining. The HCC and adjacent tissues were immersed in 4% paraformaldehyde (Beijing chemical plant, B0601002, China) for 3 days and transferred to 70% ethanol (Beijing chemical plant, B0301002, China). Then, the tissues were separately placed in processing cassettes, dehydrated through a serial alcohol gradient, and embedded in paraffin wax blocks. After that, 5-µm-thick tissue sections were dewaxed in xylene, rehydrated through decreasing concentrations of ethanol, washed in PBS and then stained with hematoxylin and eosin (HE). After staining, the sections were dehydrated through increasing concentrations of ethanol and xylene.
Cell culture and transfection. Cells were detected under a microscope and then placed in an incubator.
Twenty-four hours before transfection, the cells were plated at a concentration of approximately 1 × 10 6 /well into six-well culture plates with DMEM/HIGH GLUCOSE (GIBCO, 41965120, USA) containing 10% fetal bovine serum (FBS; PAA, A15-151, Austria) and 1% penicillin-streptomycin in a 37 °C humidified atmosphere with 5% CO 2 . The working concentration of penicillin and streptomycin was 100 U/mL and 100 μg/mL, respectively. The DMEM/HIGH GLUCOSE was replaced with serum-free Opti-MEM (GIBCO, Grand Island, NY, USA) when the cell confluency reached more than 80%. Luciferase assay. The miR-302a mimics, MAP3K2-3′UTR-WT/PBX3-3′UTR-WT recombinant plasmids, which contained potential target sites (AGCACTTT) of miR-302a, and MAP3K2-3′UTR-mut/PBX3-3′UTR-mut containing mutant MAP3K2/PBX3 3′UTR binding sites (ACACTCCA) were purchased from Gene-Pharma Company in China. For luciferase activity detection, the DMEM/HIGH GLUCOSE was replaced with serum-free Opti-MEM (GIBCO, 31985062, USA) when the cell confluency reached more than 80%, and 150 µL serum-free Opti-MEM was mixed with 5 µL Lipofectamine 2000 and 1.25 µL (20 µmol) of the miR-302a mimics and 500 ng of pmiR-RB-REPORT vectors for transfection. At 48 h after the transfection, the cells were harvested, and the luciferase activity was measured using a Dual Luciferase Reporter Gene Assay kit (Promega, E1960, USA) according to the manufacturer's instructions. Three biological replicates were conducted.
QPCR analysis. Total RNA from cells or tissues was extracted using TRIzol reagent (Invitrogen, 15596026, USA). Primer mix, miR-302a and U6 primers were designed for cDNA synthesis using a qPCR RT Kit (TOYOBO, FSQ-101, Japan). The PCR reaction solution (20 μL) was prepared according to the instructions for SYBR Premix Ex Taq (TaKaRa, DRR081A, Japan) under the following conditions: 95 °C for 1 min; followed by 40 cycles of 95 °C for 5 s and 60 °C for 30 s. U6 and β-actin were used as internal controls. Three biological replicates were conducted. The data were analyzed using SPSS 20.0 software, and the 2 −ΔΔCT method was used according to the following formula:
Here, 2−ΔΔCt refers to the relative expression ratio and relative expression levels were calculated using the 2 −ΔΔCt method.
Western blot analysis. The total protein in cells or tissues was extracted using RIPA buffer (BOSTER, AR0105, China). The protein concentration was determined using the BCA method (KeyGEN BioTECH, KGP902, China), and 40 μg of protein from each sample was separated on 10% SDS-PAGE gels and then transferred to 0.45-µm PVDF membranes (Millipore, IPVH00010, USA) with 150 mA current for 1 h. Skim milk (5%) was used as the blocking solution and incubated with the membranes at 37 °C for 1 h. Then, the membranes were incubated with anti-MAP3K2 Cell proliferation analysis. Cell proliferation was analyzed using an MTT assay (Sigma, M2128, USA) according to the manufacturer's instructions. HepG2 cell and SMMC-7721 cells (100 µL containing 5 × 10 3 cells) suspensions were added to each well in a 96-well plate and incubated for 12 h. HepG2 cells were respectively transfected with miR-302a mimics, inhibitor and miR-shNC vectors using Lipofectamine 2000. For the reverse experiment, HepG2 cell and SMMC-7721 cells treated with miR-302a mimics were transfected with a MAP3K2/PBX3 overexpression vector. At different time points (0 h, 12 h, 24 h, 36 h,48 h and 72 h), the culture medium was removed and replaced with culture medium containing 10 μL of sterile MTT dye (5 mg/mL). After incubation at 37 °C for 4 h, the MTT solution was removed, and 150 μL of dimethyl sulfoxide (DMSO) was added to dissolve the formazan crystals. Spectrometric absorbance at 450 nm was measured with a BioTek Synergy2 microplate photometer (BioTek, Synergy2, USA). Three biological replicates were conducted.
Cell apoptosis analysis. Cells were harvested and reseeded in six-well plates at a density of 1 × 10 6 cells per well after 48 h of transfection. HepG2 cell and SMMC-7721 cells were respectively transfected with miR302a mimics, inhibitor and miR-shNC vectors using Lipofectamine 2000. For the reverse experiment, miR302a-treated cells were transfected with MAP3K2/PBX3 overexpression vector. An Annexin V-FITC/PI apoptosis detection kit was used for apoptosis assays (Keygen Biotech, Nanjing, China). After resuspension in 400 μL of Annexin V binding buffer, the cells were incubated with 5 µL of FITC-conjugated Annexin V and 5 µL of PI for 15 min in the dark at room temperature. The early (Annexin V+/PI−) and late apoptotic (Annexin V+/PI+) cells were analyzed using a FACScan flow cytometer (BD Biosciences, San Diego, CA, USA).
Statistical analysis. The data are reported as the mean ± standard deviation (SD). For comparison of the two study groups, statistical analysis was performed using Student's t-test. Differences among three groups were analyzed using Fisher's least significant difference (LSD) method or Dunnett T3 two-way analysis of variance (ANOVA) using SPSS 19.0 software (IBM Corp. Armonk, NY, USA). Values of P < 0.05 were regarded as statistically significant.
